Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Case 9 - The man without a plan
Published online by Cambridge University Press: 19 October 2021
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Summary
Pretest self-assessment question (answer at the end of the case)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 95 - 102Publisher: Cambridge University PressPrint publication year: 2021
References
Adler, LA, Spencer, T, Brown, TE, et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder. J ClinPsychopharmacol 2009; 29:44–50. https://doi.org/10.1097/jcp.0b013e318192e4a0Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Association, 2013.Google Scholar
Berlin, RK, Butler, PM, Perloff, MD. Gabapentin therapy in psychiatric disorders. Prim Care Companion CNS Disord 2015; 17:28–32. https://doi.org/10.4088/pcc.15r01821Google Scholar
Bymaster, FP, Katner, JS, Nelson, DL, . Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rats: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002; 27:699–711. https://doi.org/10.1016/s0893-133x(02)00346-9Google Scholar
Clayton, AH, Gillespie, EH. Bupropion. In: Schatzberg, AF, Nemeroff, CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology, 4th edn. Washington, DC: American Psychiatric Publishing, 2009; p. 415.Google Scholar
Girard, R, Joober, R. Treatment of ADHD in patients with bipolar disorder. J Psychiatry Neurosci 2017; 42:E11–12. https://doi.org/10.1503/jpn.170097CrossRefGoogle ScholarPubMed
Gitlin, MJ. Antidepressants in bipolar depression: an enduring controversy. Int J Bipolar Disord 2018; 6:3–6. https://doi.org/10.1186/s40345-018-0133-9Google Scholar
Klassen, LJ, Katzman, MA, Chokka, P. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord 2010; 124:1–8. https://doi.org/10.1016/j.jad.2009.06.036Google Scholar
Li, D-J, Tseng, P-T, Chen, Y-W, et al. Significant treatment effect of bupropion in patients with bipolar disorder but similar phase-shifting rate as other antidepressants: a meta-analysis following the PRISMA guidelines. Medicine 2016; 95:e3165. https://doi.org/10.1097/md.0000000000003165Google Scholar
Mahableshwarkar, AR, Zajecka, J, Jacobson, W, et al. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 2015; 40:2025–37. https://doi.org/10.1038/npp.2015.52Google Scholar
Marangoni, C, de Chiara, L, Faedda, GL. Bipolar disorder and ADHD: comorbidity and diagnostic distinctions. Curr Psychiatry Rep, 2015; 17:1–2. https://doi.org/10.1007/s11920-015-0604-yCrossRefGoogle ScholarPubMed
McIntyre, RS, Kennedy, SH, Soczynska, JK, et al. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the International Mood Disorders Collaborative Project. Prim Care Companion J Clin Psychiatry 2010; 12: e1–7. https://doi.org/10.4088/pcc.09m00861gryGoogle ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017.Google Scholar
Stahl, SM, Morrissette, DA, Faedda, G, et al. Guidelines for the recognition and management of mixed depression. CNS Spectr 2017; 22:203–19. https://doi.org/10.1017/s1092852917000165Google Scholar
Thase, ME. Effects of venlafaxine on blood pressure. J Clin Psychiatry 1998; 59: 502–8. https://doi.org/10.4088/jcp.v59n1002CrossRefGoogle ScholarPubMed
Tzellos, TG, Papazisis, G, Toulis, KA, et al. A2δ ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia 2010; 14:71–5.Google ScholarPubMed
Wilens, TE, Morrison, NR, Prince, J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 2011; 11:1443–65. https://doi.org/10.1586/ern.11.137Google Scholar